On March 31st, Charles River announced the acquisition of Argenta and BioFocus, global leaders in discovery services. The integration of their early discovery capabilities into our discovery portfolio allows us to engage with clients as a full-service, early-stage CRO with unparalleled integrated in vitro and in vivo capabilities, from target discovery through preclinical development.
We are very excited that www.argentadiscovery.com and www.biofocus.com are now incorporated into the Charles River website, providing you with integrated discovery services information in a single location.
Please navigate our updated Drug Discovery section by clicking through the key services listed on top, and explore how our significantly enhanced capabilities can accelerate your drug discovery programs.
Charles River is committed to supporting your needs for drug discovery and development every step of the way. Should you have any feedback on the website or additional questions on how we can support you, please feel free to contact us.
Argenta Discovery 2009 Ltd: Registered in England and Wales No.06920289.
BioFocus DPI Limited: Registered in England and Wales No.04622227.
Registered Offices: Charles River, Manston Road, Margate, Kent CT9 4LT.